Internal Medicine, Endocrinology, Diabetes, & Metabolism · Old Forge, PA
NPI
1154300036
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
5
Hospital affiliations
939 Moosic Rd
Old Forge, PA, 18518
Phone (570) 471-3506
Medicare paid, 2024
$68K
704 services
Medicare patients, 2024
505
Average age 74
Drug cost, 2024
$605K
4,433 prescriptions
Company payments, 2025
$15.26
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharon Palushock was code 99214 (office e&m - established), 337 times for 281 patients. In total Sharon Palushock billed 704 services in 5 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 337 | 281 | $77.07 | $26K |
| 99215 Office E&M - Established | Office | 281 | 186 | $122.78 | $35K |
| 99443 Telephone Services | Office | 54 | 44 | $80.07 | $4,324 |
| 99205 Office E&M - New | Office | 17 | 17 | $137.90 | $2,344 |
| 99213 Office E&M - Established | Office | 15 | 14 | $50.24 | $754 |
By year: 2022 $69K for 739 services; 2023 $69K for 722 services; 2024 $68K for 704 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharon Palushock prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,332 prescriptions and refills. In total Sharon Palushock wrote 4,433 Medicare prescriptions that cost $605K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,332 | 2,430 | 239 | $94K |
| Levothyroxine Sodium Generic | 945 | 2,093 | 192 | $8,880 |
| Liothyronine Sodium Generic | 194 | 380 | 53 | $6,045 |
| Metformin Hcl Generic | 180 | 362 | 37 | $1,019 |
| Losartan Potassium Generic | 108 | 204 | 20 | $754 |
| Glimepiride Generic | 106 | 278 | 28 | $1,996 |
| Glipizide Generic | 99 | 243 | 27 | $1,614 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 95 | 189 | 18 | $28K |
| Metformin Hcl Er Metformin Hcl | 85 | 219 | 23 | $1,115 |
| Jardiance Empagliflozin | 83 | 177 | 18 | $101K |
| Ozempic Semaglutide | 74 | 109 | 15 | $93K |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 64 | 125 | 13 | $20K |
| Methimazole Generic | 63 | 161 | 22 | $1,198 |
| Glipizide Er Glipizide | 51 | 119 | 11 | $840 |
| Novolin N Insulin Nph Human Isophane | 51 | 86 | Under 11 | $9,865 |
Brand drugs: 2,196 claims; generic drugs: 2,028 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharon Palushock $15.26 ($15.26 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $15.26.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $15.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.